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ABSTRACT
Objectives: The aims of our study were to assess the correlation between the amniotic fluid index (AFI) value and the 
frequency and type of fetal anomalies. 
Material and methods: The material included 94 patients at the third trimester of pregnancy, 60 with mild polyhydramnios, 
19 with moderate one, and 15 with severe one. Polyhydramnios was diagnosed if AFI was > 24 cm. All patients were divided 
into three groups based on the value of AFI: 1) mild polyhydramnios with AFI between 24.1 and 29.9 cm, 2) moderate 
polyhydramnios with AFI between 30–34.9 cm, and 3) severe polyhydramnios with AFI ≥ 35 cm.
Results: The incidence of fetal malformations correlated significantly with the degree of polyhydramnios and was the 
highest in patients with severe polyhydramnios (53.3%, p = 0.002). Congenital malformations of the gastrointestinal tract 
were the most frequent fetal anomalies in the whole group of patients (5.3%). Trisomy 18 was the most frequent aneuploidy 
found in women with polyhydramnios (2.1%).
Conclusions:
1. The incidence of fetal congenital anomalies significantly increases with the degree of polyhydramnios, being most 
frequent in severe one and rather rare in a mild one.
2. Congenital malformations of the gastrointestinal tract were the most frequent anomalies in patients with polyhy-
dramnios, especially in women with severe polyhydramnios.
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INTRODUCTION
Polyhydramnios, which is an increased amount of amniotic 
fluid, complicates approximately 1–2% of all pregnancies [1, 2]. 
The diagnosis is made by two-dimensional ultrasound finding 
of the amniotic fluid index (AFI) > 24 cm or the maximal amni-
otic pocket (MAP) > 8 cm [3]. Increased value of MAP is the only 
criterion to diagnose polyhydramnios in multiple pregnancy.
Fetal congenital anomalies are among the most fre-
quent causes of polyhydramnios, including gastrointestinal 
tract anomalies, central nervous system defects, musculo-
skeletal anomalies, airway malformation and congenital 
diaphragmatic hernia (CDH) [3]. 
It seems that not only the finding of polyhydramnios, but 
also the value of AFI have a significant effect on a fetal and 
neonatal outcome, including the frequency of birth defects 
[3, 4]. Congenital anomalies were most frequently found in 
pregnancies complicated by severe polyhydramnios [4].
OBJECTIVES
The main aim of our study was to assess the correlation 
between the AFI value and the frequency of fetal anoma-
lies. The second aim was to analyse the type of malforma-
tions and its association with the degree of polyhydramnios.
MATERIAL AND METHODS
This was a retrospective study conducted among pa-
tients, at the third trimester of pregnancy, hospitalized be-
tween the years 2008 and 2016 at Division of Reproduction 
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of Poznań University of Medical Sciences, in whom polyhy-
dramnios was diagnosed.
Polyhydramnios was diagnosed if the AFI was > 24 cm. If 
more results of the AFI from one patient were obtained, the 
maximal value of the AFI was taken. All patients were divided 
into three groups based on the value of AFI: 1) mild polyhy-
dramnios with AFI between 24.1 and 29.9 cm, 2) moderate 
polyhydramnios with AFI between 30 and 34.9 cm, and 3) 
severe polyhydramnios with AFI ≥ 35 cm.
The material included 94 patients, 60 with mild polyhy-
dramnios, 19 with moderate one, and 15 with severe one.
An eventual presence of fetal malformations, type of 
fetal anomalies and other clinical characteristics including 
the presence of congenital infection and pre- or gestational 
diabetes were analyzed.
Statistical analysis was performed using SigmaStat 
3.5 (Systat Software Inc). For parametric variables, one way 
analysis of variance (ANOVA) test was used. For non-para-
metric variables Kruskal-Wallis one way ANOVA on ranks 
test with pairwise multiple comparison procedures (Dunn’s 
method) was used. To analyze the distribution of quality 
characteristics, chi-square and Freeman-Halton extension 
of Fisher’s exact test were used. A p-value < 0.05 was con-
sidered to be statistically significant. 
RESULTS
Most of the patients (63.8%) were diagnosed with mild 
polyhydramnios, 20.2% with moderate one, and nearly 16% 
with severe one.
The mean value of AFI was 39 cm (35–51) in a severe 
polyhydramnios group, 32 cm (34.5–40) in a moderate poly-
hydramnios group, and 26 cm (24–30) in patients with mild 
polyhydramnios. 
In 68.1% of patients idiopathic polyhydramnios was di-
agnosed, most frequently in women with mild polyhydram-
nios (82.6%). Congenital infection by Toxoplasma gondi was 
found only in two patients with mild polyhydramnios. The 
frequency of diabetes did not differ between groups, but 
was the most frequent among patients with moderate poly-
hydramnios. Gestational age at delivery was not statistically 
different among the three groups of patients. The clinical 
characteristics of patients are presented in Table 1.
The general frequency of fetal anomalies in the studied 
group of patients with polyhydramnios was 21.3%, includ-
ing 11.7% in patients with mild polyhydramnios, 26.3% 
in patients with moderate polyhydramnios and 53.3% in 
patients with severe polyhydramnios. The incidence of fetal 
malformations correlated significantly with the degree of 
polyhydramnios (p = 0.002, Figure 1). 
Table 1. Clinical characteristics of patients with polyhydramnios
Mild polyhydramnios
(n = 60)
Modereate polyhydramnios
(n = 19)
Severe polyhydramnios
(n = 15) p-value
Maternal age
(years)
Mean (SD)
29 (6) 30 (6) 30 (5) 0.641 
Gestational age at diagnosis
(week)
Mean (SD)
34 (4) 32 (4) 33 (± 5) 0.114 
AFI value (maximal)
[cm]
Median (range)
26 (24–30)*, ** 32 (30–34.5)** 39 (35–51)* < 0.001
Congenital infection
(pos./neg.) 2/57 0/19 0/15 1.0
Diabetes during pregnancy
(pos./neg.)
(%)
5/55
(9.1)
3/16
(18.7)
1/14
(7.1) 0.494
Gestational age at delivery
(week)
Mean (SD)
39 (2) 37 (4) 37 (2) 0.226 
Mode of delivery
Number
(%)
CS 27 (45%)
VB 27 (45%)
VE 6 (10%)
CC 12 (63.2%)
VB 5 (26.3%)
VE 1 (5.3%)
CC 7 (46.7%)
VB 4 (26.7%)
VE 4 (26.7%)
0.157 
Newborns birth weigh
[g]
Mean (SD)
3510 (675) 2955 (1000) 3230 (735) 0.154 
CS — cesarean section; VB — spontaneous vaginal birth; VE — vacuum extractor; SD — standard deviation. *p < 0.05 vs. severe polyhydramnios, 
**p < 0.05 vs. moderate polyhydramnios
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Among all studied groups, the general frequencies of fetal 
central nervous system and gastrointestinal tract anomalies 
were 2.1% and 5.3%, respectively, including the two cases of 
fetal duodenal atresia, one of fetal ileus and the other of Dan-
dy-Walker syndrome in patients with severe polyhydramnios. 
In all patients with polyhydramnios, other fetal anoma-
lies than malformations of the central nervous system or gas-
trointestinal tract were found in 13 (13.8%) women. Among 
them, the most frequent was CDH, which was found in three 
fetuses (3.2%), including two in women with mild polyhy-
dramnios and skeletal dysplasias, also diagnosed in three 
fetuses, but two in the group with severe polyhydramnios.
Trisomy 18 was the most frequently diagnosed genetic 
syndrome in patients with polyhydramnios (2.1%).
The frequencies of all fetal anomalies in the three groups 
of patients are presented in Table 2. 
DISCUSSION
It is well known, that polyhydramnios is associated with 
the increased risk of different fetal congenital anomalies [3–5]. 
In the population studied, the incidence of fetal malforma-
tions was approximately 10 times higher than the general 
prevalence of fetal congenital anomalies in Europe according 
to the European Surveillance of Congenital Anomalies [6]. 
The most frequent form of polyhydramnios was an idi-
opathic one, found in approximately 68% of patients. It is 
consistent with other literature data [7, 8]. 
Most of the studied patients were diagnosed with mild 
polyhydramnios, which usually represents more than 60% 
of pathology [9, 10]. This form of polyhydramnios was also 
associated with the lowest frequency of congenital anoma-
lies in our study which is consistent with data presented 
by other authors [4, 9, 10]. However the frequency of fetal 
anomalies in patients with mild polyhydramnios differed in 
our study from other data and was lower than that described 
by Pri-Paz et al. [4], but higher than that found by Dashe et 
al [10]. In severe polyhydramnios, both in our study and in 
other ones [9, 10], the prevalence of fetal malformations was 
the highest exceeding 50%. The extremely high incidence 
of abnormal results (79.1%) of fetal anatomy scan in fetuses 
of mothers with AFI ≥ 35 cm was found by Pri-Paz et al. [4].
Interestingly, both in the whole studied population and 
in patients with severe polyhydramnios, we found lower 
prevalence of fetal central nervous system anomalies than in 
other studies [4, 11, 12]. More frequently, especially in se-
vere polyhydramnios group, we found fetal gastrointestinal 
malformations, which was comparable to the incidence 
described by other authors [4, 11]. 
In comparison with the results of other studies [4, 11, 
12], we did not find any case of cardiac malformation, which 
was the most frequently diagnosed anomaly in foetuses of 
mother with polyhydramnios, described by Pri-Paz et al. [4] 
and Boito et al. [12]. 
The fact of quite high incidence of CDH and skeletal dys-
plasia in fetuses of mothers with polyhydramnios was worth 
emphasizing. The first anomaly was rather more frequent 
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Figure 1. The frequency of fetal anomalies in patients with mild, 
moderate, and severe polyhydramnios
Table 2. Detailed anaylsis of all anomalies in three groups of patients
Mild polyhdramnios
(n = 60)
 Moderete polyhydramnios
(n = 19)
Severe polyhydramnios
(n = 15)
Gastrointestinal tract anomalies
n (%) Esophageal atresia — 1 (1.7) Esophageal atresia — 1 (5.3)
Duodenal atresia — 2 (13.3)
Ileus — 1 (6.7)
Central nervous system 
anomalies
n (%)
Hydrocephalus — 1 (1.7) Dandy-Walker syndrome — 1 (6.7)
Other anomalies 
n (%)
ES — 1 (1.7)
CDH — 1 (1.7)
GS — 1 (1.7)
CHD — 1 (1.7)
Ovarian cyst — 1 (1.7)
Fetal goiter — 1 (5.3)
NIH — 1 (5.3)
Skeletal dysplasia — 1 (5.3)
ES — 1 (5.3)
Oral/palate cleft — 1 (6.7)
Skeletal dysplasia — 2 (13.4)
CDH — 1 (6.7)
All (%) 7 (11.7) 5 (26.3) 8 (53.3)
ES — Edwards syndrome; CDH — congenital diaphragmatic hernia; GS — gastroschisis; NIH — non-immune hydrops; SD — standard deviation
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in case of mild polyhydramnios and the second one in the 
group with severe polyhydramnios, which is consistent with 
other literature data [4, 12]. 
Results of our study indicate also a rare frequency of 
congenital infection as a cause of polyhydramnios. Among 
all patients we found only two cases with infection of Toxo-
plasma gondii (2.1%). It is similar to the results of the larger 
study by Pasquini et al. [7] who found only 1% of patients 
with congenital infections and polyhydramnios, including 
two with Parvovirus B19 and one with Toxoplasma gondii. 
In both studies congenital infections were found only in 
patients with mild or moderate polyhydramnios.
In comparison with other studies [12, 13] we observed 
fewer cases of diabetes in patients with polyhydramnios, most 
of them in the group with moderate polyhydramnios and only 
one in women with severe one. This result might be explained 
by better metabolic control in our diabetic group. Although 
the incidence of diabetes was approximately 10% in patients 
with polyhydramnios, it was approximately 20.9% and 14.9%, 
respectively, as observed by Yefet et al. [13] and Boito et al. [12].
Like in other studies [4, 12], we found a low incidence 
of polyploidy in patients with polyhydramnios (2.1%). In 
a study published by Pri-Paz [4] the most frequent chro-
mosomal aberration was trisomy 18. Another quite fre-
quent aneuploidy found in women with polyhydramnios 
is trisomy 21 [12]. The incidence of all genetic disorders in 
fetuses of women with polyhydramnios is higher and may 
exceed 13% [12]. It includes, except aneuploidies, other 
rare genetic disorders, for example, single-gene disorders 
or microdeletion syndromes [12]. Lack of the information 
on the incidence of rare genetic diseases in our materials is 
a consequence of limited possibilities to perform molecular 
diagnostics in fetus. 
CONCLUSIONS
The incidence of fetal congenital anomalies significantly 
increases with the degree of polyhydramnios, being most 
frequent in severe one and rather rare in a mild one.
Congenital malformations of the gastrointestinal tract are 
the most frequent congenital anomalies in patients with poly-
hydramnios, especially in women with severe polyhydramnios.
Polyhydramnios is associated with a quite high inci-
dence of fetal CDH and skeletal dysplasia and a very low 
frequency of congenital infections.
The precise measurement of AFI is important because 
indicates on high or low risk of a presence of fetal congenital 
malformations what is crucial when counselling the patients.
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